Other
Modification of Series B Redeemable Convertible Preferred Stock
Analysis
StatementCash Flow Statement
SectionOther
CategoryLeverage
SignalContext dependent
VolatilityModerate
First reportedQ1 2024
Last reportedQ4 2025Mar 30, 2026
How to read this metric
Significant modifications may signal changes in investor rights or capital structure restructuring.
Detailed definition
This metric captures adjustments to the carrying value of redeemable or convertible preferred stock, often due to change...
Peer comparison
Specific to companies with complex capital structures involving preferred equity.
Metric ID:
other_stockholders_equity_modification_of_temporary_equityHistorical Data
5 periods
| Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q4 '25 | |
|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | $0.00 | $4.20M |
Range$0.00 – $4.20M
Modification of Series B Redeemable Convertible Preferred Stock at Other Companies
Frequently Asked Questions
- What is Veradermics 's modification of series b redeemable convertible preferred stock?
- Veradermics (MANE) reported modification of series b redeemable convertible preferred stock of $4.20M in Q4 2025.
- What does modification of series b redeemable convertible preferred stock mean?
- Non-cash adjustments to the value of preferred stock due to changes in terms.